Research Paper Volume 13, Issue 24 pp 25799—25845
DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival
Figure 10. The correlation between the expression of ARHGAP30 and immune inhibitors. (A) Heat map of Spearman correlations between ARHGAP30 expression and immune inhibitors across human cancers. (B1–B21) Scatter plots showing the positive correlation between ARHGAP30 expression and immune inhibitors in the treatment of lung adenocarcinoma.